EUVIMEDEUVIMED entdecken
Crossref

The PICS Endotype Hypothesis: A Neuroimmunometabolic Framework for Precision GLP-1 Neurorecovery

Irami Araújo Filho

Clinical Sciences and Clinical Research · 24.07.2026 · 5 (2)

DOI: 10.58489/2836-8959/021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Sciences and Clinical Research, online erschienen am 24.07.2026. Verfasst von Irami Araújo Filho.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-intensive care syndrome (PICS) encompasses cognitive, physical, and psychiatric impairments that persist after critical illness. The construct has organized survivorship care, but it is defined by what survivors experience rather than by the biology that produces it. This symptom-level definition may help explain why broad, undifferentiated interventions have yielded inconsistent results.

Objective

We argue for disaggregating PICS into biologically defined subtypes and outline a testable framework for mechanism-matched neurorecovery, using glucagon-like peptide-1 (GLP-1) receptor agonists as a worked example. Hypothesis: We propose that PICS is best understood not as one condition but as a family of overlapping neuroimmunometabolic processes—microglial activation, blood-brain barrier disruption, insulin resistance, endothelial injury, gut dysbiosis, and unremitting catabolism. Framework: Drawing on the logic that resolved acute respiratory distress syndrome into subphenotypes, we set out eight candidate mechanistic axes (putative endotype dimensions to be tested empirically) and map the documented actions of GLP-1 receptor agonists onto each. The mapping is deliberately two-sided: it marks axes where these agents are mechanistically promising and the catabolic-sarcopenic axis, where, by promoting weight loss, they may instead cause harm unless paired with anabolic co-therapy. Translational implications: Operationalizing the framework will require validated biomarkers, deeply phenotyped survivor cohorts, unsupervised methods to test whether the proposed clusters are real rather than imposed, and endotype-stratified trials.

Conclusion

For PICS, GLP-1 receptor agonism is investigational and unapproved; endotype-guided precision neurorecovery remains to be empirically validated. The framework's value is heuristic—it supplies a falsifiable plan rather than a treatment—and its central claim is that moving PICS from a symptom-defined syndrome toward a biologically stratified one may be a prerequisite for testing rational neurorecovery strategies.

Zitieren

APA

Filho, I. A. (2026). The PICS Endotype Hypothesis: A Neuroimmunometabolic Framework for Precision GLP-1 Neurorecovery. Clinical Sciences and Clinical Research, 5(2). https://doi.org/10.58489/2836-8959/021

Vancouver

Filho IA. The PICS Endotype Hypothesis: A Neuroimmunometabolic Framework for Precision GLP-1 Neurorecovery. Clinical Sciences and Clinical Research. 2026;5(2). doi:10.58489/2836-8959/021

BibTeX
@article{Filho2026,
  author = {Filho, Irami Araújo},
  title = {The PICS Endotype Hypothesis: A Neuroimmunometabolic Framework for Precision GLP-1 Neurorecovery},
  journal = {Clinical Sciences and Clinical Research},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.58489/2836-8959/021}
}
Kostenlos starten →